technology graph

Preclarus®: Dynamic Visualizations

Preclarus® dashboards deliver unprecedented reporting scope that exceeds functional-based study reporting. Business logic is embedded within the dashboards make visible the essential decision-making criteria needed to conduct a successful trial.

Preclarus dashboards offer interactive visualizations of operational, patient and lab data that are powered by advanced analytic capabilities to give research teams the ability to identify trends and drill down into the data for more detailed information. Preclarus users can create customized dashboard views to filter and mark specific data points and view the details behind data visualizations.

The transparency that Preclarus dashboards provide supports greater operational efficiency as well as closer, more strategic collaborations across teams resulting in more profound insights, more effective problem-solving and better overall operational efficiency.

Clients are able to access three key Preclarus dashboards that allow for rapid visual exploration of study and laboratory data to yield deeper insights, the patient data dashboard, the sponsor study operations dashboard and the scorecard dashboard.

Patient data dashboard — offers standardized and consolidated data from multiple sources to provide study teams, including medical reviewers, clinical reviewers, biostaticians and data managers, with detailed, near real-time analysis of accumulating patient data.

Sponsor study operations dashboard — presents a holistic oversight of study, country and site startup, maintenance, patient recruitment and monitoring activities, and closeout progress. Study operations teams can review key operational metrics and performance data in near real-time on individual studies and across a book of business.

Scorecard dashboard — helps executive management successfully navigate the complexities of portfolio and relationship management. Clients can maximize performance by objectively managing relationships across an entire book of business by therapeutic area, phase and status.